The FDA recorded six novel drug approvals in July 2026. A US approval creates no rights in Japan — here is the official route by which an overseas-approved medicine gets taken up for Japanese review.
Carbon ion radiotherapy sits on Japan’s Advanced Medical Care A list as technique No. 2. Here is the official wording, the cost structure, and the seven hospitals the ministry lists.
A roundup of notable developments from Japan’s pharmaceutical industry, reported by AnswersNews on 27 July 2026. Otsuka’s ADHD drug approved
According to AnswersNews’ 2026 industry rundown, Switzerland’s Roche retained the top position in global pharmaceutical sales for a third consecutive
Pfizer Japan has launched Nurtec ODT (rimegepant, brand name ナルティークOD錠 75mg), the first oral CGRP-receptor antagonist available in Japan for
Japan has added Amchepry (raguneprocel) — the world’s first commercialized iPS cell–derived product — to public insurance at ~¥55.3 million. What the Sumitomo Pharma / Kyoto University Parkinson’s therapy is, and what its conditional approval means.
Susumu Tonegawa, the first Japanese Nobel laureate in medicine, has died at 86. A tribute to his work on antibody diversity and memory — and to Japan’s six Nobel laureates in Physiology or Medicine.
A plain-language glossary for reading Japanese regenerative-medicine trials: jRCT, recruitment status, Phase I/II, eligibility and exclusion criteria, primary endpoints, adverse events, and conditional, time-limited approval.
A look at how Boots in the UK links its Health Hub, Online Doctor and Pharmacy First services together, and how regulatory information is presented alongside them.
How common OTC medicines in Japan are organised by symptom — colds, pain relief, rhinitis, gastrointestinal and eye care — with the risk classes, contraindicated groups and the points at which a pharmacist should be consulted.
